Parmax Pharma Ltd — Important, 02-05-2026: Company Update

Parmax Pharma's Board of Directors has approved the re-appointment of Dr. Umang Gosalia as Managing Director for a five-year term, starting June 28, 2026, until June 27, 2031. This decision, which follows input from the Nomination and Remuneration Committee, is contingent on shareholder approval. Dr. Gosalia, with a Ph.D. in Organic Chemistry and over 15 years of experience, has overseen production activities since 2016. His continued leadership is key for the company's operational stability and future strategy.